Download PDF
Semin intervent Radiol 2011; 28(3): 303-313
DOI: 10.1055/s-0031-1284457
© Thieme Medical Publishers

Balloon-occluded Retrograde Transvenous Obliteration (BRTO): Technique and Intraprocedural Imaging

Saher S. Sabri1 , Wael E. A. Saad1
  • 1Division of Interventional Radiology, Department of Radiology and Medical Imaging, University of Virginia Health System, Charlottesville, Virginia
Further Information

Publication History

Publication Date:
15 August 2011 (online)

Also available at
    Permissions and Reprints

ABSTRACT

Balloon-occluded retrograde transvenous obliteration (BRTO) is an endovascular technique used as a therapeutic adjunct or alternative to transjugular intrahepatic shunts (TIPS) in the management of gastric varices. Occlusion balloons are strategically placed to modulate flow within the gastrorenal or gastrocaval shunt to allow stagnation of the sclerosant material within the gastric varix. The approach and complexity of the procedure depends on the anatomic classification of inflow and outflow veins of the varix. Ethanolamine oleate has been described as the main sclerosant used in this procedure. Recently, foam sclerosants have gained popularity as alternative embolization agents, which provide the advantage of better variceal wall contact and potentially less dose of sclerosant.

KEYWORDS

Gastric varices - portal hypertension - liver cirrhosis - BRTO - portosystemic shunt - embolization

REFERENCES

  • 1 Sarin S K, Lahoti D, Saxena S P, Murthy N S, Makwana U K. Prevalence, classification and natural history of gastric varices: a long-term follow-up study in 568 portal hypertension patients.  Hepatology. 1992;  16 (6) 1343-1349
    CrossrefPubMedGoogle Scholar
  • 2 Kim T, Shijo H, Kokawa H et al.. Risk factors for hemorrhage from gastric fundal varices.  Hepatology. 1997;  25 (2) 307-312
    CrossrefPubMedGoogle Scholar
  • 3 Ryan B M, Stockbrugger R W, Ryan J M. A pathophysiologic, gastroenterologic, and radiologic approach to the management of gastric varices.  Gastroenterology. 2004;  126 (4) 1175-1189
    CrossrefPubMedGoogle Scholar
  • 4 Rössle M, Haag K, Ochs A et al.. The transjugular intrahepatic portosystemic stent-shunt procedure for variceal bleeding.  N Engl J Med. 1994;  330 (3) 165-171
    CrossrefPubMedGoogle Scholar
  • 5 Rössle M, Siegerstetter V, Olschewski M, Ochs A, Berger E, Haag K. How much reduction in portal pressure is necessary to prevent variceal rebleeding? A longitudinal study in 225 patients with transjugular intrahepatic portosystemic shunts.  Am J Gastroenterol. 2001;  96 (12) 3379-3383
    PubMedGoogle Scholar
  • 6 Tripathi D, Therapondos G, Jackson E, Redhead D N, Hayes P C. The role of the transjugular intrahepatic portosystemic stent shunt (TIPSS) in the management of bleeding gastric varices: clinical and haemodynamic correlations.  Gut. 2002;  51 (2) 270-274
    CrossrefPubMedGoogle Scholar
  • 7 Zhuang Z W, Teng G J, Jeffery R F, Gemery J M, Janne d'Othee B, Bettmann M A. Long-term results and quality of life in patients treated with transjugular intrahepatic portosystemic shunts.  AJR Am J Roentgenol. 2002;  179 (6) 1597-1603
    PubMedGoogle Scholar
  • 8 Boyer T D, Haskal Z J. American Association for the Study of Liver Diseases . The role of transjugular intrahepatic portosystemic shunt in the management of portal hypertension.  Hepatology. 2005;  41 (2) 386-400
    CrossrefPubMedGoogle Scholar
  • 9 Jalan R, Hayes P C. British Society of Gastroenterology . UK guidelines on the management of variceal haemorrhage in cirrhotic patients.  Gut. 2000;  46 (Suppl 3-4) III1-III15
    PubMedGoogle Scholar
  • 10 Abi-Jaoudeh N, Matsumoto A H, Angle J F et al.. TIPS rebleeding rates for different subtypes of varices in the era of covered stents.  J Vasc Interv Radiol. 2008;  19 (Suppl 1) S77-S78 (Abstract)
    PubMedGoogle Scholar
  • 11 Kanagawa H, Mima S, Kouyama H, Gotoh K, Uchida T, Okuda K. Treatment of gastric fundal varices by balloon-occluded retrograde transvenous obliteration.  J Gastroenterol Hepatol. 1996;  11 (1) 51-58
    CrossrefPubMedGoogle Scholar
  • 12 Chikamori F, Shibuya S, Takase Y, Ozaki A, Fukao K. Transjugular retrograde obliteration for gastric varices.  Abdom Imaging. 1996;  21 (4) 299-303
    CrossrefPubMedGoogle Scholar
  • 13 Hiraga N, Aikata H, Takaki S et al.. The long-term outcome of patients with bleeding gastric varices after balloon-occluded retrograde transvenous obliteration.  J Gastroenterol. 2007;  42 (8) 663-672
    CrossrefPubMedGoogle Scholar
  • 14 Chikamori F, Kuniyoshi N, Shibuya S, Takase Y. Eight years of experience with transjugular retrograde obliteration for gastric varices with gastrorenal shunts.  Surgery. 2001;  129 (4) 414-420
    CrossrefPubMedGoogle Scholar
  • 15 Kiyosue H, Mori H, Matsumoto S, Yamada Y, Hori Y, Okino Y. Transcatheter obliteration of gastric varices. Part 1. Anatomic classification.  Radiographics. 2003;  23 (4) 911-920
    CrossrefPubMedGoogle Scholar
  • 16 Kiyosue H, Mori H, Matsumoto S, Yamada Y, Hori Y, Okino Y. Transcatheter obliteration of gastric varices: Part 2. Strategy and techniques based on hemodynamic features.  Radiographics. 2003;  23 (4) 921-937 discussion 937
    CrossrefPubMedGoogle Scholar
  • 17 Fukuda T, Hirota S, Sugimoto K, Matsumoto S, Zamora C A, Sugimura K. “Downgrading” of gastric varices with multiple collateral veins in balloon-occluded retrograde transvenous obliteration.  J Vasc Interv Radiol. 2005;  16 (10) 1379-1383
    CrossrefPubMedGoogle Scholar
  • 18 Demagny A. Comparative study into the efficacy of a sclerosant product in the form of liquid or foam in echo-guided of arches of the long and short saphenous veins.  Phlebologie. 2002;  55 133-137
    PubMedGoogle Scholar
  • 19 Coleridge Smith P. Sclerotherapy and foam sclerotherapy for varicose veins.  Phlebology. 2009;  24 (6) 260-269
    CrossrefPubMedGoogle Scholar
  • 20 Gandini R, Chiocchi M, Konda D, Pampana E, Fabiano S, Simonetti G. Transcatheter foam sclerotherapy of symptomatic female varicocele with sodium-tetradecyl-sulfate foam.  Cardiovasc Intervent Radiol. 2008;  31 (4) 778-784
    CrossrefPubMedGoogle Scholar
  • 21 Gandini R, Konda D, Reale C A et al.. Male varicocele: transcatheter foam sclerotherapy with sodium tetradecyl sulfate—outcome in 244 patients.  Radiology. 2008;  246 (2) 612-618
    CrossrefPubMedGoogle Scholar
  • 22 Tan K T, Kirby J, Rajan D K, Hayeems E, Beecroft J R, Simons M E. Percutaneous sodium tetradecyl sulfate sclerotherapy for peripheral venous vascular malformations: a single-center experience.  J Vasc Interv Radiol. 2007;  18 (3) 343-351
    CrossrefPubMedGoogle Scholar
  • 23 Yamaki T, Nozaki M, Sakurai H, Takeuchi M, Soejima K, Kono T. Prospective randomized efficacy of ultrasound-guided foam sclerotherapy compared with ultrasound-guided liquid sclerotherapy in the treatment of symptomatic venous malformations.  J Vasc Surg. 2008;  47 (3) 578-584
    CrossrefPubMedGoogle Scholar
  • 24 Sabri S S, Swee W, Turba U C et al.. Bleeding gastric varices obliteration with balloon-occluded retrograde transvenous obliteration using sodium tetradecyl sulfate foam.  J Vasc Interv Radiol. 2011;  22 (3) 309-316 quiz 316
    CrossrefPubMedGoogle Scholar
  • 25 Koizumi J, Hashimoto T, Myojin K et al.. C-arm CT-guided foam sclerotherapy for the treatment of gastric varices.  J Vasc Interv Radiol. 2010;  21 (10) 1583-1587
    CrossrefPubMedGoogle Scholar
  • 26 Orsini C, Brotto M. Immediate pathologic effects on the vein wall of foam sclerotherapy.  Dermatol Surg. 2007;  33 (10) 1250-1254
    CrossrefPubMedGoogle Scholar
  • 27 Ceulen R P, Sommer A, Vernooy K. Microembolism during foam sclerotherapy of varicose veins.  N Engl J Med. 2008;  358 (14) 1525-1526
    CrossrefPubMedGoogle Scholar
  • 28 Forlee M V, Grouden M, Moore D J, Shanik G. Stroke after varicose vein foam injection sclerotherapy.  J Vasc Surg. 2006;  43 (1) 162-164
    CrossrefPubMedGoogle Scholar
  • 29 Park S J, Chung J W, Kim H C, Jae H J, Park J H. The prevalence, risk factors, and clinical outcome of balloon rupture in balloon-occluded retrograde transvenous obliteration of gastric varices.  J Vasc Interv Radiol. 2010;  21 (4) 503-507
    CrossrefPubMedGoogle Scholar

Saher S SabriM.D. 

Department of Radiology and Medical Imaging, University of Virginia Health System

Box 800170, 1215 Lee Street, Charlottesville, VA 22908

Email: ss2bp@virginia.edu